Kinarus Therapeutics Holding AG
- Jurisdiction
Switzerland - ISIN
CH0009115129 (PRFN.SW )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Read full profile
Fundamentals
- Net revenue
€17.93M - Gross margin
6.5% - EBIT
-€884.08K - EBIT margin
-4.9% - Net income
-€910.84K - Net margin
-5.1%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions